Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Health Initiative for Men | UNKNOWN |
| Regional HIV/AIDS Connection | UNKNOWN |
| AIDS Committee of Toronto | OTHER |
| Gay ZONE |
Not provided
Not provided
Not provided
Not provided
GPS is a sexual health promotion and HIV prevention peer-delivered counselling program. The GPS program has 4 parts: information provision about HIV and sexually transmitted infections, motivational interviewing counselling, sexual health behavioural skills building, and linkage to care. The adaptation grant has three goals: 1) to establish a multi-region and multi-sectoral team that can deliver the revised program across a variety of settings, 2) to learn how best to deliver this program as individual counselling program and also how to adapt this program for HIV-negative MSM, and 3) to pilot the individual program in 5 settings across Ontario and British Columbia. The research team will evaluate the pilot adaptation through mixed methods, employing a quantitative questionnaire and one-on-one semi-structured interviews.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| GPS program | Experimental | The individual GPS motivational interviewing counseling program has 4-6 sessions. Week 1: information on sexually transmitted infections and HIV disclosure laws is reviewed. Participants are introduced to the sex diary, stress exercise, and stages of change model. Week 2: a decisional balance exercise about the participant's current sexual behavior is completed and a behavioral goal is chosen. Week 3: participants explore their greatest fears and hopes about the goal, and the importance of and their confidence in achieving it. Week 4: the facilitator and participant identify triggers, automatic thoughts, counters, strategies, supports, and rewards pertaining to the pursuit of the goal and role play the new goal. 1-2 supplemental sessions may be added as needed. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| GPS program | Behavioral | GPS is a sexual health promotion and HIV prevention program. It has 4 components: provision of information on HIV and sexually transmitted infections, motivational interviewing counselling, sexual health behavioural skills building, and linkage to care in the local community (e.g., referrals to medical, social service, social, mental health, and substance use programs). Among HIV-positive men who have sex with men (MSM) GPS is associated with positive health outcomes including decreased likelihood of condomless anal sex (CAS), particularly CAS with serodiscordant partners. GPS is also associated with decreased fear of being rejected for insisting on condom use and increased condom use self-efficacy. |
| Measure | Description | Time Frame |
|---|---|---|
| Change in the number of serodiscordant condomless anal sex acts | Participants will be asked to report the number of times they engaged in anal sex in the without a condom with a partner of opposite or unknown HIV status in the past two months as part of a self-report questionnaire. This self-report questionnaire is administered at baseline, post-treatment (which is approximately 6 weeks after baseline), and at 3-month follow-up in order to measure changes over time. | Past 2 months (measured at baseline, post-treatment, and 3-month follow-up) |
| Measure | Description | Time Frame |
|---|---|---|
| Change in the number of sexual partners | Participants will be asked to report the number of sexual partners they had who are HIV-positive, HIV-negative, and of unknown HIV status in the past two months as part of a self-report questionnaire. This self-report questionnaire is administered at baseline, post-treatment (which is approximately 6 weeks after baseline), and at 3-month follow-up in order to measure changes over time. |
| Measure | Description | Time Frame |
|---|---|---|
| Change in loneliness | Measured using the University of California, Los Angeles Loneliness Scale, which is part of the self-report questionnaire. This self-report questionnaire is administered at baseline, post-treatment (which is approximately 6 weeks after baseline), and at 3-month follow-up in order to measure changes over time. | Present loneliness (measured at baseline, post-treatment, and 3-month follow-up) |
Inclusion Criteria:
Self-identify as a man; transmen are welcome
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Trevor Hart, PhD | Toronto Metropolitan University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Health Initiative for Men | Vancouver | British Columbia | V6E 1M7 | Canada | ||
| Regional HIV/AIDS Connection |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| UNKNOWN |
| The Ottawa Hospital | OTHER |
| University of Victoria | OTHER |
| University of Windsor | OTHER |
| Ottawa Hospital Research Institute | OTHER |
| Canadian Institutes of Health Research (CIHR) | OTHER_GOV |
| MAX Ottawa | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Past 2 months (measured at baseline, post-treatment, and 3-month follow-up) |
| Change in the number of receptive condomless anal sex acts | Participants will be asked to report the number of times they engaged in receptive anal sex without a condom in the past two months as part of a self-report questionnaire. This self-report questionnaire is administered at baseline, post-treatment (which is approximately 6 weeks after baseline), and at 3-month follow-up in order to measure changes over time. | Past 2 months (measured at baseline, post-treatment, and 3-month follow-up) |
| Change in the number of insertive condomless anal sex acts | Participants will be asked to report the number of times they engaged in insertive anal sex without a condom in the past two months as part of a self-report questionnaire. This self-report questionnaire is administered at baseline, post-treatment (which is approximately 6 weeks after baseline), and at 3-month follow-up in order to measure changes over time. | Past 2 months (measured at baseline, post-treatment, and 3-month follow-up) |
| Change in HIV viral load status | HIV-positive participants will be asked to report whether they had a detectable or undetectable HIV viral load at their last viral load test as part of a self-report questionnaire. This self-report questionnaire is administered at baseline, post-treatment (which is approximately 6 weeks after baseline), and at 3-month follow-up in order to measure changes over time. | Most recent viral load test (asked at baseline, post-treatment, and 3-month follow-up) |
| Change in use of HIV pre-exposure prophylaxis (PrEP) | For HIV-negative participants, participants will be asked whether they use HIV PrEP as part of a self-report questionnaire. This self-report questionnaire is administered at baseline, post-treatment (which is approximately 6 weeks after baseline), and at 3-month follow-up in order to measure changes over time. | Present use (asked at baseline, post-treatment, and 3-month follow-up) |
| Change in sexual compulsivity | Measured using the Sexual Compulsivity Scale, which is part of the self-report questionnaire. This self-report questionnaire is administered at baseline, post-treatment (which is approximately 6 weeks after baseline), and at 3-month follow-up in order to measure changes over time. | Present sexual compulsivity (measured at baseline, post-treatment, and 3-month follow-up) |
| London |
| Ontario |
| N6A 1C7 |
| Canada |
| Immunodeficiency Clinic - The Ottawa Hospital | Ottawa | Ontario | K1H 8L6 | Canada |
| Gay ZONE (Centretown Community Health Centre) | Ottawa | Ontario | K2P 2N6 | Canada |
| MAX Ottawa | Ottawa | Ontario | Canada |
| AIDS Committee of Toronto | Toronto | Ontario | M4Y 1Y5 | Canada |
| ID | Term |
|---|---|
| D000163 | Acquired Immunodeficiency Syndrome |
| D012749 | Sexually Transmitted Diseases |
| D015438 | Health Behavior |
| ID | Term |
|---|---|
| D015658 | HIV Infections |
| D000086982 | Blood-Borne Infections |
| D003141 | Communicable Diseases |
| D007239 | Infections |
| D015229 | Sexually Transmitted Diseases, Viral |
| D016180 | Lentivirus Infections |
| D012192 | Retroviridae Infections |
| D012327 | RNA Virus Infections |
| D014777 | Virus Diseases |
| D012897 | Slow Virus Diseases |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D007153 | Immunologic Deficiency Syndromes |
| D007154 | Immune System Diseases |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D001519 | Behavior |
Not provided
Not provided